Emergent Biosolutions Inc. (EBS) vs Kamada Ltd. (KMDA)
- Emergent Biosolutions Inc. EBS 6.38 −11.14%
- Kamada Ltd. KMDA 7.77 −0.77%
Emergent Biosolutions Inc. and Kamada Ltd. are both Drug Manufacturers Specialty & Generic companies. Kamada Ltd. is the larger, with a market value of $451.7M against $368.1M — 1.2× the size. Emergent Biosolutions Inc. has negative trailing earnings, so its P/E is not meaningful; Kamada Ltd. trades at 20.4×. Kamada Ltd. grew revenue faster over the last twelve months: 13.2% against −9.56%. Kamada Ltd. has the higher net margin (11.6% vs −23.0%) and the higher return on invested capital (8.47% vs −5.27%). Across the 21 metrics below, Kamada Ltd. leads on 13 and Emergent Biosolutions Inc. on 8.
Valuation
Profitability
| Metric | EBS | KMDA | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 55.87% | 40.82% | 53.94% |
| Operating margin | (8.57%) | 14.51% | 0.00% |
| Net margin | (22.96%) | 11.60% | 0.00% |
| Free cash flow margin | 11.18% | 13.72% | 0.00% |
| Return on equity | (40.29%) | 8.40% | (0.40%) |
| Return on assets | (13.95%) | 5.92% | (3.32%) |
| Return on invested capital | (5.27%) | 8.47% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack